Evaluating Ovarian Cancer Patients
Evaluating blood and urine using cfNA assays for monitoring tumor progression. Assessing platinum drugs resistance mechanisms in ovarian tumor patients in neoadjuvant and adjuvant therapies.
Written and reviewed by:
We are a highly specialized team of research scientists and medical professionals with extensive translational molecular medicine knowledge, expertise and writing experience.